NCT04100161

Brief Summary

Muscle strain injuries are a particularly frequent type of sports injury in soccer, athletics, badminton/ tennis and cross-fit fitness, thereby affecting a broad range of popular leisure time activities. Depending on severity, sports-active individuals may experience long-term functional impairment and pain. Additionally, individuals having sustained one strain injury have a substantially increased risk of injuring the same muscle again. Strain injuries lead to long-term, potentially permanent, loss of muscle mass, thereby weakening the muscle. Muscle atrophy is likely a major factor in the high re-injury risk. Further, strain injuries are associated with a long-term inflammatory response. In the current study, the investigators seek to study interventions to prevent the loss of muscle mass and elaborate on strategies to address the prolonged inflammation observed at the site of the injured muscle. The primary aim of this study is to investigate the effect of protein supplementation on the reduction of muscle atrophy following a severe muscle strain injury in comparison to a carbohydrate supplement. As a second purpose, this study aims to elaborate on findings of prolonged inflammation intra-/ intermuscular by large-scale protein analysis and the characterization of cells active at the site of injury. The study includes the following hypotheses:

  1. 1.Protein supplementation administered in combination with a gradually increasing loading regime (rehabilitation with weekly progression in load/ intensity) will be effective in reducing the injury-related loss of muscle mass.
  2. 2.The environment at the site of injury is not only pro-inflammatory, but contains proteins associated with proteolysis.
  3. 3.Cells belonging to the group of fibro-adipogenic progenitors will be accumulating intra- and inter-muscularly.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
39mo left

Started Jan 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress66%
Jan 2020Aug 2029

First Submitted

Initial submission to the registry

September 20, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 24, 2019

Completed
4 months until next milestone

Study Start

First participant enrolled

January 16, 2020

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 8, 2024

Completed
5.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2029

Expected
Last Updated

January 10, 2024

Status Verified

January 1, 2024

Enrollment Period

4 years

First QC Date

September 20, 2019

Last Update Submit

January 9, 2024

Conditions

Keywords

muscle strain, atrophy, protein, rehabilitation

Outcome Measures

Primary Outcomes (1)

  • Muscle volume

    Change in muscle volume in the injured muscle comparing immediate post injury scan with 3 months post scan plus comparison of change with healthy, contralateral muscle over the same time span.

    3 months post injury

Secondary Outcomes (15)

  • Muscle volume

    12 months post injury

  • Isokinetic muscle strength

    3 months post injury

  • Isokinetic muscle strength

    6 months post injury

  • Isokinetic muscle strength

    12 months post injury

  • Fat infiltration

    3 months post injury

  • +10 more secondary outcomes

Study Arms (2)

Protein supplementation

EXPERIMENTAL

20g protein supplementation twice daily for 3 months

Dietary Supplement: Protein supplementationProcedure: Active rehabilitation

Carbohydrate supplementation

ACTIVE COMPARATOR

20g maltodextrin supplementation twice daily for 3 months

Dietary Supplement: Carbohydrate supplementationProcedure: Active rehabilitation

Interventions

Protein supplementationDIETARY_SUPPLEMENT

Daily dose of 40 g whey protein for 3 months

Protein supplementation

Daily dose of 40 g maltodextrin for 3 months

Carbohydrate supplementation

Progressive rehabilitation following a muscle strain injury for 3 months

Carbohydrate supplementationProtein supplementation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Sports-active men and women
  • Acute muscle strain injury in either the calf muscles or the hamstring muscles
  • Visible tear at the muscle-connective tissue interface visible on an US scan as a hypo-/ hyperechoic area

You may not qualify if:

  • Unwillingness to return to sports
  • Claustrophobia
  • Daily intake of non-steroidal anti-inflammatory drugs (NSAIDs) within 3 months prior to the strain injury
  • Smoking
  • Diagnosed or suspected type I or type II diabetes
  • Diagnosed or suspected connective tissue and/or rheumatic diseases
  • Any observed organ dysfunctions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Sports Medicine Copenhagen, Bispebjerg Hospital, Nielsine Nielsen Vej 11, Building 8

Copenhagen, 2400, Denmark

Location

Related Publications (1)

  • Mertz KH, Sorensen HH, Lorentz C, Johansen E, Fredskild NU, Wulff MW, Svensson RB, Kjaer MB, Linden FH, Kjaer M, Bayer ML. Effects of Protein Supplementation During Early Rehabilitation on Muscle Volume and Function After Acute Muscle Strain Injuries: A Randomized Controlled Trial. Scand J Med Sci Sports. 2025 Apr;35(4):e70043. doi: 10.1111/sms.70043.

MeSH Terms

Conditions

Sprains and StrainsAtrophy

Condition Hierarchy (Ancestors)

Wounds and InjuriesPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Monika L Bayer, PhD

    Institute of Sports Medicine, Copenhagen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Researcher

Study Record Dates

First Submitted

September 20, 2019

First Posted

September 24, 2019

Study Start

January 16, 2020

Primary Completion

January 8, 2024

Study Completion (Estimated)

August 1, 2029

Last Updated

January 10, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Individual de-identified participant data or other documents such as study protocol will not be shared with any third party. A potential change in the data sharing plan after registration will be acknowledged as a statement in a submitted/ published manuscript. A change in the data sharing statement will furthermore be updated in the registry record.

Locations